|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 49/00 | |
| G01N 33/84 | |||
| A61K 31/192 | |||
| A61K 31/25 | |||
| A61K 31/216 |
| (11) | Number of the document | 3013372 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15803069.2 |
| Date of filing the European patent application | 2015-06-02 | |
| (97) | Date of publication of the European application | 2016-05-04 |
| (45) | Date of publication and mention of the grant of the patent | 2019-07-10 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2015/033700 |
| Date | 2015-06-02 |
| (87) | Number | WO 2015/187641 |
| Date | 2015-12-10 |
| (30) | Number | Date | Country code |
| 201462007894 P | 2014-06-04 | US |
| (72) |
SCHARSCHMIDT, Bruce, US
MOKHTARANI, Masoud, US
|
| (73) |
Immedica Pharma AB,
Norrtullsgatan 15, 113 29 Stockholm,
SE
|
| (54) | METHODS FOR TREATING UREA CYCLE DISORDERS TO PREVENT HYPERAMMONEMIC CRISES BY CONTROLLING BLOOD AMMONIA LEVELS |
| METHODS FOR TREATING UREA CYCLE DISORDERS TO PREVENT HYPERAMMONEMIC CRISES BY CONTROLLING BLOOD AMMONIA LEVELS |